Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-24 4:30 pm Sale | 13D | QuidelOrtho Corp QDEL | Carlyle Group Inc. CG | 10,327,772 15.4% | -717,230 (-6.49%) | View |
| 2024-07-15 4:30 pm Sale | 13D | QuidelOrtho Corp QDEL | Carlyle Group Inc. CG | 11,045,002 16.5% | -721,020 (-6.13%) | View |
| 2024-07-11 5:02 pm Purchase | 13G | Complete Solaria Inc. CSLR | Carlyle Group Inc. CG | 10,888,864 17.7% | 8,142,985 (+296.55%) | View |
| 2024-07-08 6:15 pm Purchase | 13D | Cano Health Inc. CANOQ | Carlyle Group Inc. CG | 2,801,906 6.7% | 2,801,906 (New Position) | View |
| 2024-06-25 5:00 pm Purchase | 13D | QuidelOrtho Corp QDEL | Carlyle Group Inc. CG | 11,766,022 17.6% | 11,766,022 (New Position) | View |
| 2024-05-14 4:30 pm Sale | 13D | QuidelOrtho Corp QDEL | Carlyle Group Inc. CG | 0 0% | -12,460,183 (Position Closed) | View |
| 2024-05-13 4:05 pm Sale | 13D | eFFECTOR Therapeutics Inc. EFTR | Carlyle Group Inc. CG | 193,195 4.1% | -4,636,696 (-96.00%) | View |
| 2024-03-29 4:30 pm Purchase | 13G | Q32 BIO INC QTTB | Carlyle Group Inc. CG | 1,102,741 9.2% | 1,102,741 (New Position) | View |
| 2024-03-05 4:10 pm Sale | 13D | Carlyle Group Inc. CG | Carlyle Group Management L.L.C. | 140,827,506 39% | -7,197,164 (-4.86%) | View |
| 2024-02-13 4:55 pm Sale | 13G | Carlyle Group Inc. CG | VANGUARD GROUP INC | 24,876,188 6.89% | -76,681 (-0.31%) | View |
| 2024-02-12 6:00 pm Sale | 13D | Jasper Therapeutics Inc. JSPR | Carlyle Group Inc. CG | 1,066,189 7.1% | -7,695,702 (-87.83%) | View |
| 2024-02-12 5:46 pm Sale | 13G | ZoomInfo Technologies Inc. ZI | Carlyle Group Inc. CG | 35,244,474 9% | -1,417,995 (-3.87%) | View |
| 2024-02-12 5:45 pm Sale | 13G | MKS INSTRUMENTS INC MKSI | Carlyle Group Inc. CG | 0 0% | -8,482,732 (Position Closed) | View |
| 2024-02-12 4:36 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 6.1% | 561,702 (+19.14%) | View |
| 2024-02-12 4:31 pm Unchanged | 13G | HilleVax Inc. HLVX | Carlyle Group Inc. CG | 1,838,486 3.8% | 0 (Unchanged) | View |
| 2024-02-12 11:22 am Sale | 13G | Carlyle Group Inc. CG | MORGAN STANLEY MS | 10,485,962 2.9% | -12,926,684 (-55.21%) | View |
| 2024-02-09 6:14 pm Purchase | 13G | Carlyle Group Inc. CG | Capital World Investors | 20,008,088 5.5% | 17,791,088 (+802.48%) | View |
| 2024-02-07 4:31 pm Purchase | 13D | Adicet Bio Inc. ACET | Carlyle Group Inc. CG | 3,060,292 4.1% | 907,333 (+42.14%) | View |
| 2024-01-25 1:48 pm Purchase | 13G | Carlyle Group Inc. CG | BlackRock Inc. BLK | 31,155,048 8.6% | 31,155,048 (New Position) | View |
| 2024-01-03 4:15 pm Purchase | 13D | CommScope Holding Company Inc. COMM | Carlyle Group Inc. CG | 42,257,593 16.6% | 2,789,051 (+7.07%) | View |